Tuesday, September 19, 2006
The NYTimes has an article here that examines the Bristol-Myers Deferred Prosecution Agreement, including the role of the monitor. Co-blogger Peter Henning is quoted in this article stating "I am not comfortable,” . . . “with the U.S. attorney at a board meeting where they are considering basic corporate policy. The government is saying this is how we want this company to be operated. The government is telling Bristol-Myers and its shareholders this is how your investment will be managed.’’ This blog previously discussed this aspect of the agreement as well as other unusual aspects of the Bristol-Myers Deferred Prosecution Agreement here.